Related Experiment Video

Updated: May 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Sodium thiosulfate therapy for calcific uremic arteriolopathy

Sagar U Nigwekar1, Steven M Brunelli, Debra Meade

  • 1Renal Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. sagarnigs@gmail.com

Clinical Journal of the American Society of Nephrology : CJASN
|March 23, 2013
PubMed

Insights

Intravenous sodium thiosulfate (STS) showed potential in treating calcific uremic arteriolopathy (CUA), a severe condition. A majority of patients experienced clinical improvement, though more research is needed for conclusive evidence.

Area of Science:

  • Nephrology
  • Vascular Medicine
  • Dermatology

Background:

  • Calcific uremic arteriolopathy (CUA) is a severe, often fatal vascular condition in dialysis patients.
  • Currently, no definitive effective treatment exists for CUA.
  • Intravenous sodium thiosulfate (STS) has been anecdotally reported but not systematically studied.

Purpose of the Study:

  • To systematically evaluate the efficacy and safety of intravenous sodium thiosulfate (STS) for treating calcific uremic arteriolopathy (CUA).

Main Methods:

  • Retrospective analysis of 172 maintenance hemodialysis patients with CUA treated with STS.
  • Data abstracted from clinical systems and physician surveys for outcomes and safety.
  • Evaluated CUA lesion improvement, mortality, laboratory values, and adverse events.

Main Results:

  • A majority of patients (73.6%) showed some level of clinical improvement in CUA lesions with STS treatment.
  • One-year mortality was 35% in patients treated with STS.
  • STS treatment led to significant reductions in serum phosphorus and parathyroid hormone levels.
  • Adverse events and laboratory abnormalities were generally mild.

Conclusions:

  • Intravenous sodium thiosulfate (STS) appears to offer clinical benefit for patients with calcific uremic arteriolopathy (CUA).
  • While not conclusive, the study suggests STS is a potentially viable treatment option.
  • Further rigorous studies are warranted to confirm efficacy and optimal use.
Abstract

Related Concept Videos

Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...